GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
BG Medicine, Inc. (BGMD) [hlAlert]

Rating:
Buy BGMD
down 95.67 %

BG Medicine, Inc. (BGMD) rated Buy with price target $1.50 by Ladenburg Thalmann

Posted on: Thursday,  Aug 8, 2013  3:25 PM ET by Ladenburg Thalmann

Ladenburg Thalmann rated Buy BG Medicine, Inc. (NASDAQ: BGMD) on 08/08/2013. Previously Ladenburg Thalmann rated Buy BG Medicine, Inc. (NASDAQ: BGMD) on
12/21/2011., when the stock price was $17.36. Since then, BG Medicine, Inc. has lost 95.68% as of 09/09/2015's recent price of $0.75.
If you would have followed the previous Ladenburg Thalmann's recommendation on BGMD, you would have lost 95.67% of your investment in 1358 days.

BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of diagnostic tests based on iomarkers. The Company?s product, the BGM Galectin-3 test for heart failure, received clearance from the Food and Drug Administration (FDA), in November 2010. Galectin-3 testing services are being offered for use by clinicians in the United States through Laboratory Corporation of America (LabCorp). The Company is also developing multiple product candidates for cardiovascular and other diseases. BG Medicine is developing its initial product candidates to address unmet needs in cardiovascular disease. In May 2010, BG Medicine entered into a license and supply agreement with LabCorp under which LabCorp began offering galectin-3 testing services to clinicians in the United States in January 2011. The galectin-3 testing services offered by LabCorp utilize the manual versions of its diagnostic test.

Our Research Department takes a fresh, critical approach to analyzing primary sources and developing proprietary research. Many individuals, institutions, portfolio managers and hedge fund managers, on all levels, have been neglected by brokerage firms ignoring the demands for unbiased research. Ladenburg Thalmann provides a superior branded in-depth research product geared only to action-oriented investment ideas. Ladenburg Thalmann’s proprietary equity research tries to uncover crucial information before the rest of the Street. Our analysts concentrate on uncovered and under-covered stocks and have a small to mid-cap focus. We will not shy away from large cap names as long as we can bring value to our clients through timely, differentiated ideas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/8/2013 3:25 PM Buy
None
4.48 6.00
as of 12/13/2013
1 Week up  83.33 %
1 Month up  77.41 %
3 Months up  22.22 %
1 YTD down  -52.38 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/21/2011 8:25 AM Buy
None
17.36 33.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy